Cancer Research Meeting Calendar  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caceres-Cortes, J. R.
Right arrow Articles by Hoang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caceres-Cortes, J. R.
Right arrow Articles by Hoang, T.
[Cancer Research 61, 6281-6289, August 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Implication of Tyrosine Kinase Receptor and Steel Factor in Cell Density-dependent Growth in Cervical Cancers and Leukemias1

Julio R. Caceres-Cortes2, Jose A. Alvarado-Moreno, Kazuo Waga, Rosalva Rangel-Corona, Alberto Monroy-Garcia, Leticia Rocha-Zavaleta, Julia Urdiales-Ramos, Benny Weiss-Steider, Andre Haman, Patrice Hugo, Roland Brousseau and Trang Hoang

Laboratories of Oncology [J. R. C-C., J. A. A-M., R. R-C., J. U-R.] and Immunobiology, [A. M-G.], Research Unit in Cell Differentiation and Cancer, Facultad de Estudios Superiores Zaragoza [B. W-S.], and Molecular Biology Department, Biomedical Research Institute [L. R-Z.] Universidad Autonoma de Mexico, Mexico 15000; Institut de Recherches en Biotechnologie, Montreal, H4P 2R2 Quebec, Canada [R. B.]; Procrea, Montreal, H4P 2R2, Quebec, Canada [P. H.]; and Laboratory of Hemopoiesis and Leukemia, Clinical Research Institute of Montreal, Montreal, H2W 1R7, Quebec, Canada [K. W., A. H., T. H.]

Cell-cell interaction is important in the expansion of leukemic cells and of solid tumors. Steel factor (SF) or Kit ligand is produced as a membrane-bound form (mSF) and a soluble form. Because both primary gynecological tumors and primary leukemic cells from patients with acute myeloblastic leukemia (AML) have been shown to coexpress c-Kit and SF, we addressed the question of whether mSF could contribute to cell interaction in these cancers. Investigations on primary cervical carcinomas have been hindered by the fact that the cells do not grow in culture. We report herein the establishment of two cervical carcinoma cell lines, CALO and INBL, that reproduce the pattern of SF/c-Kit expression observed in primary tumor samples. In addition, these cells exhibit marked density-dependent growth much in the same way as AML blasts. Using an antisense strategy with phosphorothioate-modified oligonucleotides that specifically target SF without affecting other surface markers, we provide direct evidence for a role of mSF and c-Kit in cell interaction and cell survival in these gynecological tumor cell lines as well as in primary AML blasts. Finally, our study defines the importance of juxtacrine stimulation, which may be as important, if not more, than autocrine stimulation in cancers.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Z.-B. Han, H. Ren, H. Zhao, Y. Chi, K. Chen, B. Zhou, Y.-j. Liu, L. Zhang, B. Xu, B. Liu, et al.
Hypoxia-inducible factor (HIF)-1{alpha} directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
Carcinogenesis, October 1, 2008; 29(10): 1853 - 1861.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Nakagawa, Y. Matsuno, H. Kunitoh, A. Maeshima, H. Asamura, and R. Tsuchiya
Immunohistochemical KIT (CD117) Expression in Thymic Epithelial Tumors
Chest, July 1, 2005; 128(1): 140 - 144.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. C. Heinrich, C. D. Blanke, B. J. Druker, and C. L. Corless
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
J. Clin. Oncol., March 15, 2002; 20(6): 1692 - 1703.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.